Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.

ABSTRACT:

SUBMITTER: Fisher SA 

PROVIDER: S-EPMC6353308 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature